Amdocs Statistics
Total Valuation
Amdocs has a market cap or net worth of $9.58 billion. The enterprise value is $9.84 billion.
| Market Cap | 9.58B |
| Enterprise Value | 9.84B |
Important Dates
The next estimated earnings date is Wednesday, July 31, 2024, after market close.
| Earnings Date | Jul 31, 2024 |
| Ex-Dividend Date | Jun 28, 2024 |
Share Statistics
Amdocs has 115.92 million shares outstanding.
| Shares Outstanding | 115.92M |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 97.46% |
| Float | 115.78M |
Valuation Ratios
The trailing PE ratio is 18.54 and the forward PE ratio is 11.10. Amdocs's PEG ratio is 1.01.
| PE Ratio | 18.54 |
| Forward PE | 11.10 |
| PS Ratio | 1.93 |
| Forward PS | 1.85 |
| PB Ratio | 2.70 |
| P/FCF Ratio | 14.95 |
| PEG Ratio | 1.01 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.59, with an EV/FCF ratio of 15.35.
| EV / Earnings | 18.65 |
| EV / Sales | 1.98 |
| EV / EBITDA | 11.59 |
| EV / EBIT | 14.94 |
| EV / FCF | 15.35 |
Financial Position
The company has a current ratio of 1.32, with a Debt / Equity ratio of 0.23.
| Current Ratio | 1.32 |
| Quick Ratio | 1.16 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | 0.95 |
| Debt / FCF | 1.25 |
| Interest Coverage | 21.14 |
Financial Efficiency
Return on equity (ROE) is 14.80% and return on invested capital (ROIC) is 12.80%.
| Return on Equity (ROE) | 14.80% |
| Return on Assets (ROA) | 8.20% |
| Return on Capital (ROIC) | 12.80% |
| Revenue Per Employee | $161,902 |
| Profits Per Employee | $17,198 |
| Employee Count | 30,695 |
| Asset Turnover | 0.77 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Amdocs has paid $99.62 million in taxes.
| Income Tax | 99.62M |
| Effective Tax Rate | 15.88% |
Stock Price Statistics
The stock price has decreased by -13.87% in the last 52 weeks. The beta is 0.74, so Amdocs's price volatility has been lower than the market average.
| Beta (5Y) | 0.74 |
| 52-Week Price Change | -13.87% |
| 50-Day Moving Average | 79.50 |
| 200-Day Moving Average | 85.13 |
| Relative Strength Index (RSI) | 64.54 |
| Average Volume (20 Days) | 808,326 |
Short Selling Information
| Short Interest | 2.40M |
| Short Previous Month | 2.26M |
| Short % of Shares Out | 2.39% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.61 |
Income Statement
In the last 12 months, Amdocs had revenue of $4.97 billion and earned $527.91 million in profits. Earnings per share was $4.46.
| Revenue | 4.97B |
| Gross Profit | 1.75B |
| Operating Income | 661.71M |
| Pretax Income | 627.53M |
| Net Income | 527.91M |
| EBITDA | 849.15M |
| EBIT | 658.68M |
| Earnings Per Share (EPS) | $4.46 |
Balance Sheet
The company has $544.36 million in cash and $803.28 million in debt, giving a net cash position of -$258.93 million or -$2.23 per share.
| Cash & Cash Equivalents | 544.36M |
| Total Debt | 803.28M |
| Net Cash | -258.93M |
| Net Cash Per Share | -$2.23 |
| Equity (Book Value) | 3.54B |
| Book Value Per Share | 30.58 |
| Working Capital | 437.50M |
Cash Flow
In the last 12 months, operating cash flow was $759.97 million and capital expenditures -$118.89 million, giving a free cash flow of $641.09 million.
| Operating Cash Flow | 759.97M |
| Capital Expenditures | -118.89M |
| Free Cash Flow | 641.09M |
| FCF Per Share | $5.50 |
Margins
Gross margin is 35.16%, with operating and profit margins of 13.32% and 10.62%.
| Gross Margin | 35.16% |
| Operating Margin | 13.32% |
| Pretax Margin | 12.63% |
| Profit Margin | 10.62% |
| EBITDA Margin | 17.09% |
| EBIT Margin | 13.25% |
| FCF Margin | 12.90% |
Dividends & Yields
This stock pays an annual dividend of $1.92, which amounts to a dividend yield of 2.32%.
| Dividend Per Share | $1.92 |
| Dividend Yield | 2.32% |
| Dividend Growth (YoY) | -11.05% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 42.96% |
| Buyback Yield | 3.39% |
| Shareholder Yield | 5.71% |
| Earnings Yield | 5.51% |
| FCF Yield | 6.69% |
Analyst Forecast
The average price target for Amdocs is $103.80, which is 25.54% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $103.80 |
| Price Target Difference | 25.54% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Amdocs has an Altman Z-Score of 4.71 and a Piotroski F-Score of 7.
| Altman Z-Score | 4.71 |
| Piotroski F-Score | 7 |